CNTB vs TXT · rev $64.0K vs P/E 19, rev $7.52B
Connect Biopharma Holdings Ltd (CNTB) versus Textron Inc (TXT) — a side-by-side from cached financials, not a winner call.
Connect Biopharma Holdings Ltd (CNTB) is a biotechnology company listed on US.
Textron Inc (TXT) is a aerospace & defense company listed on US.
Latest reported CNTB revenue for 2025-12-31 was $64.0K. Net income was -$55.5M. Revenue was down 99.8% from 2024-12-31 to 2025-12-31. CNTB currently screens at market cap $63.3M.
Latest reported TXT revenue for 2026-07-04 was $7.52B. Net income was $468.0M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
CNTB currently screens at market cap $63.3M. TXT currently screens at market cap $14.85B and trailing P/E 18.5.
Not investment advice. Open the CNTB and TXT stock pages for the full models.
Not investment advice.